References
- Singh G , TriadafilopoulosG. Epidemiology of NSAID induced gastrointestinal complications. J. Rheumatol. Suppl.56, 18–24 (1999).
- Rakesh KP , ManukumarHM, GowdaDC. Schiff's bases of quinazolinone derivatives: synthesis and SAR studies of a novel series of potential anti-inflammatory and antioxidants. Bioorg. Med. Chem. Lett.25(5), 1072–1077 (2015).
- Rakesh KP , RameshS, ManukumarHM, ChandanS, GowdaDC. Quinazolinones linked amino acids derivatives as a new class of promising antimicrobial, antioxidant and antiinflammatory agents. Eur. J. Med. Chem.6(3), 254–260 (2015).
- James MW , HawkeyCJ. Assessment of non-steroidal anti-inflammatory drug (NSAID) damage in the human gastrointestinal tract. Br. J. Clin. Pharmacol.56(2), 146–155 (2003).
- Vega J , GoeckeH, MéndezGP, GuardaFJ. Nephrotic syndrome and acute tubular necrosis due to meloxicam use. Ren. Fail.34(10), 1344–1347 (2012).
- Adebayo D , BjarnasonI. Is non-steroidal anti-inflammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy?Postgrad. Med. J.82(965), 186–191 (2006).
- Chen X , LengJ, RakeshKPet al. Synthesis and molecular docking studies of xanthone attached amino acids as potential antimicrobial and anti-inflammatory agents. Med. Chem. Commun.8(8), 1706–1719 (2017).
- Karthik CS , ManukumarHM, SandeepSet al. Development of piperazine-1-carbothioamide chitosan silver nanoparticles (P1C-Tit*CAgNPs) as a promising anti-inflammatory candidate: a molecular docking validation. Med. Chem. Commun.9(4), 713–724 (2018).
- ChenLi MB , SridharaKP, RakeshKPet al. Multi-targeted dihydrazones as potent biotherapeutics. Bioorg. Chem.81, 389–395 (2018).
- Karthik CS , ManukumarHM, AnandaAPet al. Synthesis of novel benzodioxane midst piperazine moiety decorated chitosan silver nanoparticle against biohazard pathogens and as potential anti-inflammatory candidate: a molecular docking studies. Int. J. Biol. Macromol.108, 489–502 (2018).
- Henry DA . Side-effects of non-steroidal anti-inflammatory drugs. Baillieres Clin. Rheumatol.2(2), 425–454 (1988).
- Arroyo M , LanasA. NSAIDs-induced gastrointestinal damage. Review. Minerva Gastroenterol. Dietol.52(3), 249–259 (2006).
- Wallace JL , VongL. NSAID-induced gastrointestinal damage and the design of GI-sparing NSAIDs. Curr. Opin. Investig. Drugs9(11), 1151–1156 (2008).
- Bias P , BuchnerA, KlesserB, LauferS. The gastrointestinal tolerability of the LOX/COX inhibitor, licofelone, is similar to placebo and superior to naproxen therapy in healthy volunteers: results from a randomized, controlled trial. Am. J. Gastroenterol.99(4), 611–618 (2004).
- Velázquez C , RaoPNP, McDonaldR, KnausEE. Synthesis and biological evaluation of 3,4-diphenyl-1,2,5-oxadiazole-2-oxides and 3,4-diphenyl-1,2,5-oxadiazoles as potential hybrid COX-2 inhibitor/nitric oxide donor agents. Bioorg. Med. Chem.13(8), 2749–2757 (2005).
- Hunt RH , BarkunAN, BaronDet al. Recommendations for the appropriate use of anti-inflammatory drugs in the era of the coxibs: defining the role of gastroprotective agents. J. Gastroenterol.16(4), 231–240 (2002).
- Wang S , ZhaG, RakeshKPet al. Synthesis of benzo[d]thiazole-hydrazone analogues: molecular docking and SAR studies of potential H+/K+ ATPase inhibitors and antiinflammatory agents. Med. Chem. Commun.8(6), 1173–1189 (2017).
- Wang R . Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter?FASEB J.16(13), 1792–1798 (2002).
- Fiorucci S , DistruttiE, CirinoG, WallaceJL. The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver. Gastroenterology131(1), 259–271 (2006).
- Magierowski M , MagierowskaK, KwiecienS, BrzozowskiT. Gaseous mediators nitric oxide and hydrogen sulfide in the mechanism of gastrointestinal integrity, protection and ulcer healing. Molecules20(5), 9099–9123 (2015).
- Wallace JL . Hydrogen sulfide-releasing anti-inflammatory drugs. Trends Pharmacol. Sci.28(10), 501–505 (2007).
- Calderone V , MartelliA, TestaiL, CitiV, BreschiMC. Using hydrogen sulfide to design and develop drugs. Expert Opin. Drug Discov.11(2), 163–175 (2016).
- Wallace JL , FerrazJG, MuscaraMN. Hydrogen sulfide: an endogenous mediator of resolution of inflammation and injury. Antioxid. Redox Signal.17(1), 58–67 (2012).
- Zanardo RCO , BrancaleoneV, DistruttiE, FiorucciS, CirinoG, WallaceJL. Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J.20(12), 2118–2120 (2006).
- Wallace JL , IanaroA, FlanniganKL, CirinoG. Gaseous mediators in resolution of inflammation. Semin. Immunol.27(3), 227–233 (2015).
- Stuart-Smith K . Demystified. nitric oxide. Mol. Pathol.55(6), 360–366 (2002).
- Epstein FH , MoncadaS, HiggsA. The L-arginine-nitric oxide pathway. N. Engl. J. Med.329(27), 2002–2012 (1993).
- Murad F . Regulation of cytosolic guanylyl cyclase by nitric oxide: the NO-cyclic GMP signal transduction system. Adv. Pharmacol.26, 19–33 (1994).
- Hallas J , DallM, AndriesAet al. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study. Br. Med. J.333(7571), 726–730 (2006).
- Wallace J . Nonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred years. Gastroenterology112(3), 1000–1016 (1997).
- Katti S , YeoleP, JadhavV, PatilV. Synthesis, molecular docking and evaluation of anti-inflammatory activity of some 5-alkyl/aryl 2-amino-1,3,4 thiadiazole derivatives. Der Pharma Chem.8(9), 1–8 (2016).
- Pandey A , RajavelR, ChandrakerS, DashD. Synthesis of Schiff bases of 2-amino-5-aryl-1,3,4-thiadiazole and its analgesic, anti-inflammatory and anti-bacterial activity. E-J. Chem.9(4), 2524–2531 (2012).
- Hu Y , LiC, WangX, YangY, ZhuH. 1,3,4-Thiadiazole: synthesis, reactions, and applications in medicinal, agricultural, and materials chemistry. Chem. Rev.114(10), 5572–5610 (2014).
- Paprocka R , WieseM, EljaszewiczAet al. Synthesis and anti-inflammatory activity of new 1,2,4-triazole derivatives. Bioorg. Med. Chem. Lett.25(13), 2664–2667 (2015).
- Ahmadi F , GhayahbashiMR, SharifzadehMet al. Synthesis and evaluation of anti-inflammatory and analgesic activities of new 1,2,4-triazole derivatives. Med. Chem.11(1), 69–76 (2014).
- Zhao Y , BhushanS, YangCet al. Controllable hydrogen sulfide donors and their activity against myocardial ischemia-reperfusion injury. ACS Chem. Biol.8(6), 1283–1290 (2013).
- Winter CA , RisleyEA, NussGW. Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs. Exp. Biol. Med.111(3), 544–547 (1962).
- Meshali M , El-SabbaghH, FodaA. Effect of encapsulation of flufenamic acid with acrylic resins on Its bioavailability and gastric ulcerogenic activity in rats. Acta Pharm. Technol.29, 217–230 (1983).
- Robert A , NezamisJE, PhillipsJP. Effect of prostaglandin E1 on gastric secretion and ulcer formation in the rat. Gastroenterology55(4), 481–487 (1968).
- Hassan GS , Abou-SeriSM, KamelG, AliMM. Celecoxib analogs bearing benzofuran moiety as cyclooxygenase-2 inhibitors: design, synthesis and evaluation as potential anti-inflammatory agents. Eur. J. Med. Chem.76, 482–493 (2014).
- Selinsky BS , GuptaK, SharkeyCT, LollPJ. Structural analysis of NSAID binding by prostaglandin H2 synthase: time-dependent and time-independent inhibitors elicit identical enzyme conformations. Biochemistry40(17), 5172–5180 (2001).
- Orlando BJ , LucidoMJ, MalkowskiMG. The structure of ibuprofen bound to cyclooxygenase-2. J. Struct. Biol.189(1), 62–66 (2015).
- Chemical Computing Group, Inc., Montréal . MOE (2015). www.chemcomp.com
- Montalbetti CAGN , FalqueV. Amide bond formation and peptide coupling. Tetrahedron61(46), 10827–10852 (2005).
- Shirote PJ , BhatiaMS. Synthesis, characterization and anti-inflammatory activity of 5-{[((5-Substituted-aryl)-1,3,4-thiadiazol-2-yl)thio]-n-alkyl}-1,3,4-oxadiazole-2-thiol. Chin. J. Chem.28(8), 1429–1436 (2010).
- Allegretti M , BertiniR, CestaMCet al. 2-arylpropionic CXC chemokine receptor 1 (CXCR1) ligands as novel noncompetitive CXCL8 inhibitors. J. Med. Chem.48(13), 4312–4331 (2005).